Antimicrobial activity and time kill curve study of newly synthesized dialkyl carboxylate cyclohexane derivative; A novel anti-Pseudomonas aeruginosa compound
Abstract
Pseudomonas aeruginosa causes nosocomial infections, ventilator-associated pneumonia and high morbidity and mortality in immunocompromised and cystic fibrosis patients. Development of the high level of resistance to multiple antibiotics and lack of new drugs accentuate the need of new antimicrobial substances against this opportunistic pathogen. A novel dimethyl carboxylate cyclohexane derivative was synthesized and initially screened against four Gram-positive bacteria and four Gram-negative bacteria by agar well diffusion method. Minimum inhibitory concentration (MIC) was determined against all test pathogens using resazurin dye by broth microdilution method. Effect of test compound on growth curve of Pseudomonas aeruginosa BDU-49 was evaluated by turbidimetric method. Time kill assay was performed to assess bacteriostatic or bactericidal nature and relationship between the concentration of the test compound and the net growth rate of Pseudomonas aeruginosa BDU-49. Test compound exhibited better antimicrobial activity against Gram-negative bacteria. Pseudomonas aeruginosa BDU-49 was the most susceptible test culture with MIC 62.5 μg mL-1. The growth curves of Pseudomonas aeruginosa BDU-49 demonstrated that test compound could inhibit the growth and reproduction of bacteria. Time kill assay showed that test compound is bactericidal at 2× MIC and bacteriostatic at MIC. Overall, these data indicate that test substance could act as probable novel anti-Pseudomonas aeruginosa compound in future.
Downloads
References
.
Copyright (c) 2022 Acta Scientiarum. Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 3.0 (CC BY 3.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 3.0 properly.